Vincerx Pharma, Inc. (Nasdaq: VINC) announces that the previously signed binding Term Sheet between Vincerx, Oqory, Inc., and Vivasor, Inc. for a reverse merger transaction has been terminated. As a result, the board of directors will reassess the Company’s strategic alternatives, including out-licensing, merger and acquisition opportunities (including reverse mergers), the sale of assets and technologies, and winding down operations, among other potential transactions.
Read the full article: Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives //
Source: https://www.globenewswire.com/news-release/2025/02/28/3035045/0/en/Vincerx-Pharma-Announces-Termination-of-Reverse-Merger-Term-Sheet-and-Evaluation-of-Strategic-Alternatives.html